Breast cancer is a heterogeneous disease comprising four primary molecular subtypes, defined in large part by the expression status of hormone receptors (HR), including estrogen receptor (ER), progesterone receptor (PR) and HER2 receptor tyrosine kinase (RTK). This evidence concerns the gene PGR and breast cancer.